-
November 17-18: Network Meta-Analysis in Relative Effectiveness Research- Virtual
-
Different HTA Perspectives on Reliably Estimating Treatment Effects
-
November 6: Developing Decision-Grade Real-World Evidence - In Person at ISPOR Europe 2022
-
November 6: Understanding Survival Modeling with Application to HTA - In Person at ISPOR Europe 2022
-
November 6: Introduction to Health Technology Assessment - In Person at ISPOR Europe 2022
Introduction to Health Technology Assessment LEVEL: Introductory TRACK: Health Technology Assessment LENGTH: 4 Hours | Course runs 1 day This short course will be offered in-person at the ISPOR Europe 2022 conference. Separate registration is required. Visit the ISPOR Europe 2022 website to register and learn more.
-
November 6: Alternative Economic Assessment for Expressing Healthcare Value and Informing Resource Allocation Decisions - In Person at ISPOR Europe 2022
-
November 6: Applied Cost-Effectiveness Modeling with R - In Person at ISPOR Europe 2022
-
November 6: Statistical Methods for Health Economics & Outcomes Research - In Person at ISPOR Europe 2022
-
November 6: Elements of Pharmaceutical/Biotech Pricing - In Person at ISPOR Europe 2022
-
November 6: Reimbursement Systems for Pharmaceuticals in Europe - In Person at ISPOR Europe 2022
-
November 6: Health Economic Modeling in R: A Hands-on Introduction - In Person at ISPOR Europe 2022
-
November 6: Going Beyond the Standard: Exploring Advanced Survival Modeling Techniques - In Person at ISPOR Europe 2022
-
November 6: Advanced Decision Modeling for Health Economic Evaluations - In Person at ISPOR Europe 2022
-
November 6: Introduction to the Design & Analysis of Observational Studies of Treatment Effects Using Retrospective Data Sources - In Person at ISPOR Europe 2022
-
November 6: Risk-Sharing/Performance-Based Arrangements in Developing Countries - In Person at ISPOR Europe 2022
-
HEOR Theater - Inclusive & Representative: How RWE Can Help to Fill Gaps Left by Clinical Trials
1:00PM-1:45PM EDT
-
HEOR Theater - Patients and Caregivers as Partners in Health Preference Research
11:00AM-11:45AM EDT
-
October 19: Metamodeling for Simulation-Based Optimization of Strategies in Healthcare- Virtual
-
Can the Benefits From Biosimilars be Sustainably Increased? Policy Recommendations for Europe, Middle East and Canada
-
October 12-13: Study Design with Real-World Data- Virtual
